美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant

0.0558

-0.0142-20.29%

成交量：200.00

成交額：11.15

市值：22.90萬

市盈率：- -

高：0.0558

開：0.0557

低：0.0557

收：0.0700

52周最高：0.1560

52周最低：0.0200

股本：410.45萬

流通股本：410.45萬

量比：1.64

換手率：0.00%

股息：- -

股息率：- -

淨資產收益率：-127.46%

總資產收益率：-71.91%

市淨率：-0.06

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

60 Degrees Pharmaceuticals攜手Runway Health為國際旅行者提供瘧疾預防藥物Arakoda®直供服務

60度製藥公司讚助研究顯示：北卡羅來納州立大學同行評審發現24%慢性疲勞患者存在巴貝西蟲感染

60 Degrees Pharmaceuticals 宣佈 B-Free 慢性巴貝斯病研究的臨牀試驗中心已開放病人入組，地點位於西奈山伊坎醫學院

60 Degrees Pharmaceuticals宣佈在複發性巴貝斯蟲病研究中，首位患者接受塔非喹治療後未發現巴貝斯蟲感染

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SXTPW"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTPW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","market":"US","secType":"STK","nameCN":"60 Degrees Pharmaceuticals Equity Warrants Exp 16 May 2028 Warrant","latestPrice":0.0558,"timestamp":1770913219425,"preClose":0.07,"halted":0,"volume":200,"delay":0,"changeRate":-0.2028571428571429,"floatShares":4104469,"shares":4104469,"eps":0,"marketStatus":"交易中","change":-0.0142,"latestTime":"02-12 11:31:21 EST","open":0.0557,"high":0.0558,"low":0.0557,"amount":11.1499994,"amplitude":0.001429,"askPrice":0.0721,"askSize":1555,"bidPrice":0.0558,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770930000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.07,"volumeRatio":1.637664},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTPW\",,,,,undefined,":{"symbol":"SXTPW","floatShares":4104469,"roa":"-71.91%","roe":"-127.46%","lyrEps":0,"volumeRatio":1.637664,"shares":4104469,"dividePrice":0,"high":0.0558,"amplitude":0.001429,"preClose":0.07,"low":0.0557,"week52Low":0.02,"pbRate":"-0.06","psRate":"0.50","week52High":0.156,"institutionHeld":0,"latestPrice":0.0558,"committee":-0.217221,"eps":0,"divideRate":0,"volume":200,"delay":0,"ttmEps":0,"open":0.0557,"prevYearClose":0.0628,"prevWeekClose":0.0683,"prevMonthClose":0.0572,"prevQuarterClose":0.0628,"fiveDayClose":0.0683,"twentyDayClose":0.055,"sixtyDayClose":0.0402},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTPW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTPW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTPW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTPW\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1111655792","title":"60 Degrees Pharmaceuticals攜手Runway Health為國際旅行者提供瘧疾預防藥物Arakoda®直供服務","url":"https://stock-news.laohu8.com/highlight/detail?id=1111655792","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111655792?lang=zh_tw&edition=fundamental","pubTime":"2026-01-22 21:02","pubTimestamp":1769086950,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals与Runway Health达成战略合作，将共同为国际旅行者开辟Arakoda疟疾预防药物的直接获取渠道。该合作旨在通过数字化健康平台，为出境人员提供便捷的疟疾预防解决方案。此次合作将整合60 Degrees Pharmaceuticals在热带病防治领域的专业优势与Runway Health的创新医疗服务平台，确保旅行者能够及时获得经临床验证的疟疾预防药物。Arakoda作为美国FDA批准的新型疟疾预防药物，其便捷的用药方案特别适合长期跨境旅行者需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","SXTPW","BK4007"],"gpt_icon":0},{"id":"1145415013","title":"60度製藥公司讚助研究顯示：北卡羅來納州立大學同行評審發現24%慢性疲勞患者存在巴貝西蟲感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1145415013","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145415013?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 21:02","pubTimestamp":1767013374,"startTime":"0","endTime":"0","summary":"一项由60度制药公司资助、在北卡罗来纳州立大学开展的同行评审研究揭示，在表现为慢性疲劳症状的患者群体中，巴贝西虫感染的检出率高达24%。该研究成果为慢性疲劳综合征与寄生虫感染之间的潜在关联提供了新的临床证据。\n研究数据表明，近四分之一长期受困于不明原因疲劳的患者，其症状可能与巴贝西虫属原虫感染存在病理学联系。这一发现不仅为慢性疲劳的病因诊断开辟了新视角，也可能推动相关靶向治疗方案的开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP","SXTPW"],"gpt_icon":0},{"id":"1104126707","title":"60 Degrees Pharmaceuticals 宣佈 B-Free 慢性巴貝斯病研究的臨牀試驗中心已開放病人入組，地點位於西奈山伊坎醫學院","url":"https://stock-news.laohu8.com/highlight/detail?id=1104126707","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104126707?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 21:01","pubTimestamp":1763730076,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals 宣布 B-Free 慢性巴贝斯病研究的临床试验中心现已开放病人入组，地点位于西奈山伊坎医学院。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"1144509557","title":"60 Degrees Pharmaceuticals宣佈在複發性巴貝斯蟲病研究中，首位患者接受塔非喹治療後未發現巴貝斯蟲感染","url":"https://stock-news.laohu8.com/highlight/detail?id=1144509557","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144509557?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 19:15","pubTimestamp":1760526909,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals宣布在复发性巴贝斯虫病研究中，首位患者接受塔非喹治疗后未发现巴贝斯虫感染。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","SXTPW","BK4007"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SXTPW\",params:#limit:6,delay:false,,,undefined,":[]}}